Fresenius Kabi Pharmaceuticals Holding, Inc. announced today that it has filed its Form 10-Q with the Securities and Exchange Commission. APP Pharmaceuticals, Inc., which was acquired by Fresenius Kabi Pharmaceuticals Holding, Inc., is a member of the Fresenius Kabi Group. The Form 10-Q details the Company's unaudited financial statements for the quarter ending September 30, 2010.
The Form 10-Q has been posted to APP's Web site at and is also available at the Securities and Exchange Commission's Web site at
No comments:
Post a Comment